March 06, 2026

Thermogenetics: How Proteins Are Controllable by Heat

Thermogenetics: How Proteins Are Controllable by Heat

Modular design strategy makes it possible to precisely control cellular functions through minimal temperature changes

Protein activity can be precisely regulated via subtle changes in temperature using heat-sensitive switches. Underlying this capability is a novel modular design strategy developed by researchers at the Institute of Pharmacy and Molecular Biotechnology of Heidelberg University. The strategy allows the integration of sensory domains in various proteins regardless of function or spatial structure. This new Heidelberg approach in the field of thermogenetics is broadly applicable and opens up new possibilities for precise, non-invasive control of different cellular processes. It was developed by a research team led by Prof. Dr Dominik Niopek and Dr Jan Mathony.

Proteins that change their spatial structure in response to small temperature pulses are ideal as molecular tools for thermal control of cells. | © Benedict Wolf

Proteins are the molecular machines of the cell. They regulate nearly all vital processes and their responses are highly dynamic. To better understand these processes and their chronological sequence, scientists need tools that can be used to change individual parameters precisely and in a controlled manner. The most suitable proteins are those that can be turned on and off like technical devices. Especially attractive in this context are heat-sensitive protein switches that tightly regulate the temperature spatiotemporally and are able to deeply penetrate tissue or complex biological samples as a signal.

Until now, temperature-dependent control of proteins was considered technically difficult and highly limited. Most available methods allow only indirect control by means of gene expression. The Heidelberg researchers solved this problem. They integrated optimized variants of a plant sensory domain into natural proteins, in order to develop so-called allosteric thermoswitches. These switches respond with high precision to minimal changes in temperature within the physiological temperature window of human cells, which is between 37 and 40 degrees Celsius. Thus, protein activity can be altered to tightly control cellular functions.

“Our goal was to make temperature usable as a versatile stimulus for protein control,” explains Ann-Sophie Kröll, a doctoral candidate in Dr Mathony’s team. To verify feasibility, the new approach was first tested and refined using the Escherichia coli bacterium. Then the researchers transferred their strategy to mammal cells and engineered temperature-controllable CRISPR-Cas gene editors, whose activity can be finely regulated. “Using these allosteric thermoswitches, we are able to directly and reversibly control cellular functions without actively intervening in other processes of the cell,” explains Prof. Niopek, who heads the Pharmaceutical Biology department at the Institute of Pharmacy and Molecular Biotechnology.

One major characteristic of this new approach is its high modularity. In addition to the sensory domain originally used, the researchers were also able to integrate an alternative receptor module into proteins that likewise responds to temperature changes. The modular design strategy of the Heidelberg researchers thus offers a general blueprint for engineering temperature-controlled protein switches. They can be integrated independently of the function or spatial structure of the given proteins and open up new possibilities for the precise control of various cellular processes without the need to intervene in the cell, thus enabling non-invasive control. 

“We want to further develop thermogenetics into a comprehensive and broadly applicable technology that can be used in future to precisely regulate nearly every protein solely through heat. We are now at the threshold of the possible in this field,” states junior research group leader Jan Mathony. According to Dominik Niopek, the results present new perspectives for basic research. “They also promise great potential for future biomedical applications,” adds Prof. Niopek.

The research was funded by the Baden-Württemberg Foundation, the German Research Foundation, and the European Research Council. The results were published in the journal “Nature Chemical Biology”.


Original publication

A.S. Kroell, K.H. Hoffmann, N.A. Motzkus, N. Lemmen, N. Happ, B. Wolf, A.L. von Bachmann, N. Southern, F. Vogd, S. Aschenbrenner, D. Niopek, and J. Mathony: Modular engineering of thermoresponsive allosteric proteins. Nature Chemical Biology (published online 12 February 2026),

Our latest News

discover more
Nobel-Potential Discovery from VectorBuilder Scientists Reveals Fundamental Mechanisms of Development

Nobel-Potential Discovery from VectorBuilder Scientists Reveals Fundamental Mechanisms of Development

Chicago, April 21, 2026 – One of the most fundamental questions in biology is how a single fertilized egg produces the diverse cell types making up the body – from neurons and skin to muscle and blood – that bear the same genetic blueprint but distinct expression patterns. Now, a research team lead by Dr. Bruce Lahn, […]

Wo Zukunft entsteht: Deutschlands „Innovationsmaschinenräume“ präsentieren sich auf der re:publica 2026

Wo Zukunft entsteht: Deutschlands „Innovationsmaschinenräume“ präsentieren sich auf der re:publica 2026

Wie kann aus wissenschaftlicher Forschung eine konkrete medizinische Therapie entstehen? Im Maschinenraum der Life Sciences leistet bioRN Life Science Cluster genau das: Unter anderem beim Thema Frauengesundheit Heidelberg, 30 April 2026: Frauen sterben früher und werden oft schlechter therapiert. Der Grund dafür: Die medizinische Forschung und Entwicklung waren lange Zeit überwiegend auf männliche Populationen ausgerichtet. […]

AGC Biologics Wins 2026 Fierce Outsourcing Award for Leadership in Regulatory and Quality Compliance

AGC Biologics Wins 2026 Fierce Outsourcing Award for Leadership in Regulatory and Quality Compliance

Global CDMO recognized for exceptional quality systems and regulatory track record; named finalist in Excellence in Client Service & Partnership and Manufacturing Operations categories SEATTLE – April 27, 2026 – AGC Biologics, your friendly CDMO expert, is the 2026 recipient of the Fierce Outsourcing Award for Leadership in Regulatory and Quality Compliance. The award recognizes the […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp